Cargando…

Methodology for computing the burden of disease of adverse events following immunization

PURPOSE: Composite disease burden measures such as disability‐adjusted life‐years (DALY) have been widely used to quantify the population‐level health impact of disease or injury, but application has been limited for the estimation of the burden of adverse events following immunization. Our objectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: McDonald, Scott A., Nijsten, Danielle, Bollaerts, Kaatje, Bauwens, Jorgen, Praet, Nicolas, van der Sande, Marianne, Bauchau, Vincent, de Smedt, Tom, Sturkenboom, Miriam, Hahné, Susan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055877/
https://www.ncbi.nlm.nih.gov/pubmed/29575242
http://dx.doi.org/10.1002/pds.4419
_version_ 1783341267824934912
author McDonald, Scott A.
Nijsten, Danielle
Bollaerts, Kaatje
Bauwens, Jorgen
Praet, Nicolas
van der Sande, Marianne
Bauchau, Vincent
de Smedt, Tom
Sturkenboom, Miriam
Hahné, Susan
author_facet McDonald, Scott A.
Nijsten, Danielle
Bollaerts, Kaatje
Bauwens, Jorgen
Praet, Nicolas
van der Sande, Marianne
Bauchau, Vincent
de Smedt, Tom
Sturkenboom, Miriam
Hahné, Susan
author_sort McDonald, Scott A.
collection PubMed
description PURPOSE: Composite disease burden measures such as disability‐adjusted life‐years (DALY) have been widely used to quantify the population‐level health impact of disease or injury, but application has been limited for the estimation of the burden of adverse events following immunization. Our objective was to assess the feasibility of adapting the DALY approach for estimating adverse event burden. METHODS: We developed a practical methodological framework, explicitly describing all steps involved: acquisition of relative or absolute risks and background event incidence rates, selection of disability weights and durations, and computation of the years lived with disability (YLD) measure, with appropriate estimation of uncertainty. We present a worked example, in which YLD is computed for 3 recognized adverse reactions following 3 childhood vaccination types, based on background incidence rates and relative/absolute risks retrieved from the literature. RESULTS: YLD provided extra insight into the health impact of an adverse event over presentation of incidence rates only, as severity and duration are additionally incorporated. As well as providing guidance for the deployment of DALY methodology in the context of adverse events associated with vaccination, we also identified where data limitations potentially occur. CONCLUSIONS: Burden of disease methodology can be applied to estimate the health burden of adverse events following vaccination in a systematic way. As with all burden of disease studies, interpretation of the estimates must consider the quality and accuracy of the data sources contributing to the DALY computation.
format Online
Article
Text
id pubmed-6055877
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-60558772018-07-30 Methodology for computing the burden of disease of adverse events following immunization McDonald, Scott A. Nijsten, Danielle Bollaerts, Kaatje Bauwens, Jorgen Praet, Nicolas van der Sande, Marianne Bauchau, Vincent de Smedt, Tom Sturkenboom, Miriam Hahné, Susan Pharmacoepidemiol Drug Saf Original Reports PURPOSE: Composite disease burden measures such as disability‐adjusted life‐years (DALY) have been widely used to quantify the population‐level health impact of disease or injury, but application has been limited for the estimation of the burden of adverse events following immunization. Our objective was to assess the feasibility of adapting the DALY approach for estimating adverse event burden. METHODS: We developed a practical methodological framework, explicitly describing all steps involved: acquisition of relative or absolute risks and background event incidence rates, selection of disability weights and durations, and computation of the years lived with disability (YLD) measure, with appropriate estimation of uncertainty. We present a worked example, in which YLD is computed for 3 recognized adverse reactions following 3 childhood vaccination types, based on background incidence rates and relative/absolute risks retrieved from the literature. RESULTS: YLD provided extra insight into the health impact of an adverse event over presentation of incidence rates only, as severity and duration are additionally incorporated. As well as providing guidance for the deployment of DALY methodology in the context of adverse events associated with vaccination, we also identified where data limitations potentially occur. CONCLUSIONS: Burden of disease methodology can be applied to estimate the health burden of adverse events following vaccination in a systematic way. As with all burden of disease studies, interpretation of the estimates must consider the quality and accuracy of the data sources contributing to the DALY computation. John Wiley and Sons Inc. 2018-03-24 2018-07 /pmc/articles/PMC6055877/ /pubmed/29575242 http://dx.doi.org/10.1002/pds.4419 Text en © 2018 The Authors. Pharmacoepidemiology & Drug Safety Published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Reports
McDonald, Scott A.
Nijsten, Danielle
Bollaerts, Kaatje
Bauwens, Jorgen
Praet, Nicolas
van der Sande, Marianne
Bauchau, Vincent
de Smedt, Tom
Sturkenboom, Miriam
Hahné, Susan
Methodology for computing the burden of disease of adverse events following immunization
title Methodology for computing the burden of disease of adverse events following immunization
title_full Methodology for computing the burden of disease of adverse events following immunization
title_fullStr Methodology for computing the burden of disease of adverse events following immunization
title_full_unstemmed Methodology for computing the burden of disease of adverse events following immunization
title_short Methodology for computing the burden of disease of adverse events following immunization
title_sort methodology for computing the burden of disease of adverse events following immunization
topic Original Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055877/
https://www.ncbi.nlm.nih.gov/pubmed/29575242
http://dx.doi.org/10.1002/pds.4419
work_keys_str_mv AT mcdonaldscotta methodologyforcomputingtheburdenofdiseaseofadverseeventsfollowingimmunization
AT nijstendanielle methodologyforcomputingtheburdenofdiseaseofadverseeventsfollowingimmunization
AT bollaertskaatje methodologyforcomputingtheburdenofdiseaseofadverseeventsfollowingimmunization
AT bauwensjorgen methodologyforcomputingtheburdenofdiseaseofadverseeventsfollowingimmunization
AT praetnicolas methodologyforcomputingtheburdenofdiseaseofadverseeventsfollowingimmunization
AT vandersandemarianne methodologyforcomputingtheburdenofdiseaseofadverseeventsfollowingimmunization
AT bauchauvincent methodologyforcomputingtheburdenofdiseaseofadverseeventsfollowingimmunization
AT desmedttom methodologyforcomputingtheburdenofdiseaseofadverseeventsfollowingimmunization
AT sturkenboommiriam methodologyforcomputingtheburdenofdiseaseofadverseeventsfollowingimmunization
AT hahnesusan methodologyforcomputingtheburdenofdiseaseofadverseeventsfollowingimmunization